Back to News
Dec 5, 2025 12:00 PM

FDA Warns Against Abbott Glucose Monitor Sensors After Reports Of Over 700 Injuries, 7 Deaths

The U.S. Food and Drug Administration (FDA) in December issued a safety alert urging people with diabetes to stop using select glucose sensors made by Abbott Laboratories’ (NYSE:ABT) Diabetes Care, after the company linked the devices to seven deaths and hundreds of serious injuries.

• Abbott Laboratories shares are consolidating. What’s ahead for ABT stock?

Regulators said certain models of the company's FreeStyle Libre 3 sensors may inaccurately show low glucose levels, potentially prompting dangerous treatment decisions.

In a notice published earlier in December, the agency said the affected FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors can produce falsely low readings.

Over time, these inaccuracies may lead users to consume ...